Expert panel workshop consensus statement on the role of the environment in the development of autoimmune disease

International Journal of Molecular Sciences

Volumn 15, Issue 8, 2014, Pages 14269-14297

  Parks, Christine G ^a   Miller, Frederick W ^a   Pollard, Kenneth Michael ^b   Selmi, Carlo ^c,d   Germolec, Dori ^a   Joyce, Kelly ^e   Rose, Noel R ^f   Humble, Michael C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e DREXEL UNIVERSITY   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Autoimmune diseases; Consensus; Environmental exposures; Epidemiology; Exposure assessment; Mechanisms; National Institute of Environmental Health Sciences (U.S.)

Indexed keywords

4, 4' ISOPROPYLIDENEDIPHENOL; AMALGAM; AROMATIC HYDROCARBON RECEPTOR; ARSENIC; AUTOANTIBODY; CADMIUM; CD45RA ANTIGEN; CHLORPHENOTANE; CIGARETTE SMOKE; DIOXIN; FREUND ADJUVANT; GAMMA INTERFERON; HLA DR4 ANTIGEN; INTERLEUKIN 4; LEAD; MERCURIC CHLORIDE; MINERAL OIL; ORGANOMERCURY COMPOUND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHTHALIC ACID; POLYCHLORINATED BIPHENYL; PRISTANE; SILICON DIOXIDE; TOLL LIKE RECEPTOR; TRICHLOROETHYLENE; UNCLASSIFIED DRUG; VITAMIN D;

ANCA ASSOCIATED VASCULITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE LIVER DISEASE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CELLULAR IMMUNODEFICIENCY; CONSENSUS DEVELOPMENT; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS INFECTION; GENOTYPE ENVIRONMENT INTERACTION; HASHIMOTO DISEASE; HUMAN; IMMUNE DYSREGULATION; INNATE IMMUNITY; META ANALYSIS (TOPIC); NATIONAL HEALTH ORGANIZATION; NONHUMAN; PROTEIN MODIFICATION; QUESTIONNAIRE; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; ULTRAVIOLET RADIATION; VITAMIN D DEFICIENCY; WORKSHOP; ADVERSE EFFECTS; AUTOIMMUNE DISEASES;

AUTOIMMUNE DISEASES; ENVIRONMENTAL EXPOSURE; HUMANS;

EID: 84922374858     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150814269     Document Type: Review

References (101)

1. Cooper, G.S.; Bynum, M.L.; Somers, E.C. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. J. Autoimmun. 2009, 33, 197-207.
2. Autoimmune Diseases Coordinating Committee, N.I.o.H. Autoimmune Diseases Research Plan. Available online: http://www.niaid.nih.gov/topics/autoimmune/Documents/adccreport.pdf (assessed on 13 August 2014).
3. Autoimmune Diseases Coordinating Committee, N.I.o.H. Report of the Autoimmune Diseases Coordinating Committee. Available online: http://www.niaid.nih.gov/topics/autoimmune/ Documents/adccrev.pdf (assessed on 13 August 2014).
4. Autoimmune Diseases Coordinating Committee. N.I.o.H. Progress in Autoimmune Diseases Research; Autoimmune Diseases Coordinating Committee, 2005; NIH Publication No. 05-5140. Available online: https://www.niaid.nih.gov/topics/autoimmune/Documents/adccfinal.pdf (assessed on 13 August 2014).
5. Jacobson, D.L.; Gange, S.J.; Rose, N.R.; Graham, N.M. Epidemiology and estimated population burden of selected autoimmune diseases in the united states. Clin. Immunol. Immunopathol. 1997, 84, 223-243.
6. Moroni, L.; Bianchi, I.; Lleo, A. Geoepidemiology, gender and autoimmune disease. Autoimmun. Rev. 2012, 11, A386-A392.
7. Bogdanos, D.P.; Smyk, D.S.; Rigopoulou, E.I.; Mytilinaiou, M.G.; Heneghan, M.A.; Selmi, C.; Gershwin, M.E. Twin studies in autoimmune disease: Genetics, gender and environment. J. Autoimmun. 2012, 38, J156-J169.
8. Cooper, G.S.; Germolec, D.; Heindel, J.; Selgrade, M. Linking environmental agents and autoimmune diseases. Environ. Health Perspect. 1999, 107, 659-660.
9. Selgrade, M.K.; Cooper, G.S.; Germolec, D.R.; Heindel, J.J. Linking environmental agents and autoimmune disease: An agenda for future research. Environ. Health Perspect. 1999, 107, 811-813.
10. Mastin, J.P. NIEHS extramural update: Environmental factors in autoimmune disease. Environ. Health Perspect. 2003, 111, A483.
11. Cooper, G.S.; Gilbert, K.M.; Greidinger, E.L.; James, J.A.; Pfau, J.C.; Reinlib, L.; Richardson, B.C.; Rose, N.R. Recent advances and opportunities in research on lupus: Environmental influences and mechanisms of disease. Environ. Health Perspect. 2008, 116, 695-702.
12. Statement, V.C. Vallombrosa consensus statement on environmental contaminants and human fertility compromise. Semin. Reprod. Med. 2006, 24, 178-189.
13. Vom Saal, F.S.; Akingbemi, B.T.; Belcher, S.M.; Birnbaum, L.S.; Crain, D.A.; Eriksen, M.; Farabollini, F.; Guillette, L.J., Jr.; Hauser, R.; Heindel, J.J.; et al. Chapel hill bisphenol a expert panel consensus statement: Integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod. Toxicol. 2007, 24, 131-138.
14. Gwinn, M.R.; DeVoney, D.; Jarabek, A.M.; Sonawane, B.; Wheeler, J.; Weissman, D.N.; Masten, S.; Thompson, C. Meeting report: Mode(s) of action of asbestos and related mineral fibers. Environ. Health Perspect. 2011, 119, 1806-1810.
15. Selmi, C.; Leung, P.S.; Sherr, D.H.; Diaz, M.; Nyland, J.F.; Monestier, M.; Rose, N.R.; Gershwin, M.E. Mechanisms of environmental influence on human autoimmunity: A national institute of environmental health sciences expert panel workshop. J. Autoimmun. 2012, 39, 272-284.
16. Miller, F.W.; Alfredsson, L.; Costenbader, K.H.; Kamen, D.L.; Nelson, L.M.; Norris, J.M.; de Roos, A.J. Epidemiology of environmental exposures and human autoimmune diseases: Findings from a national institute of environmental health sciences expert panel workshop. J. Autoimmun. 2012, 39, 259-271.
17. Germolec, D.; Kono, D.H.; Pfau, J.C.; Pollard, K.M. Animal models used to examine the role of the environment in the development of autoimmune disease: Findings from an niehs expert panel workshop. J. Autoimmun. 2012, 39, 285-293.
18. Summers, S.A.; Hoi, A.; Steinmetz, O.M.; O'Sullivan, K.M.; Ooi, J.D.; Odobasic, D.; Akira, S.; Kitching, A.R.; Holdsworth, S.R. Tlr9 and Tlr4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy. J. Autoimmun. 2010, 35, 291-298.
19. Kanta, H.; Mohan, C. Three checkpoints in lupus development: Central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation. Genes Immun. 2009, 10, 390-396.
20. Lien, E.; Zipris, D. The role of toll-like receptor pathways in the mechanism of type 1 diabetes. Curr. Mol. Med. 2009, 9, 52-68.
21. Rose, N.R. The adjuvant effect in infection and autoimmunity. Clin. Rev. Allergy Immunol. 2008, 34, 279-282.
22. Carlson, B.C.; Jansson, A.M.; Larsson, A.; Bucht, A.; Lorentzen, J.C. The endogenous adjuvant squalene can induce a chronic T cell-mediated arthritis in rats. Am. J. Pathol. 2000, 156, 2057-2065.
23. Sun, H.X.; Xie, Y.; Ye, Y.P. Advances in saponin-based adjuvants. Vaccine 2009, 27, 1787-1796.
24. Lemoine, S.; Morva, A.; Youinou, P.; Jamin, C. Regulatory B cells in autoimmune diseases: How do they work? Ann. N. Y. Acad. Sci. 2009, 1173, 260-267.
25. Shlomchik, M.J. Sites and stages of autoreactive B cell activation and regulation. Immunity 2008, 28, 18-28.
26. Dorner, T.; Jacobi, A.M.; Lipsky, P.E. B cells in autoimmunity. Arthritis Res. Ther. 2009, 11, 247.
27. Matsushita, T.; Tedder, T.F. Identifying regulatory B cells (B10 cells) that produce IL-10 in mice. Methods Mol. Biol. 2011, 677, 99-111.
28. Oukka, M. Th17 cells in immunity and autoimmunity. Ann. Rheum. Dis. 2008, 67, iii26-iii29.
29. Di Cesare, A.; di Meglio, P.; Nestle, F.O. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J. Investig. Dermatol. 2009, 129, 1339-1350.
30. Sarkar, S.; Fox, D.A. Targeting IL-17 and Th17 cells in rheumatoid arthritis. Rheum. Dis. Clin. N. Am. 2010, 36, 345-366.
31. Segal, B.M. Th17 cells in autoimmune demyelinating disease. Semin. Immunopathol. 2010, 32, 71-77.
32. Quintana, F.J.; Weiner, H.L. Environmental control of Th17 differentiation. Eur. J. Immunol. 2009, 39, 655-657.
33. Singh, N.P.; Singh, U.P.; Singh, B.; Price, R.L.; Nagarkatti, M.; Nagarkatti, P.S. Activation of Aryl hydrocarbon Receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS One 2011, 6, e23522.
34. Marshall, N.B.; Vorachek, W.R.; Steppan, L.B.; Mourich, D.V.; Kerkvliet, N.I. Functional characterization and gene expression analysis of CD4+ CD25+ regulatory T cells generated in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Immunol. 2008, 181, 2382-2391.
35. Kerkvliet, N.I. AhR-mediated immunomodulation: The role of altered gene transcription. Biochem. Pharmacol. 2009, 77, 746-760.
36. Hontecillas, R.; Bassaganya-Riera, J. Peroxisome proliferator-activated receptor γ is required for regulatory CD4+ T cell-mediated protection against colitis. J. Immunol. 2007, 178, 2940-2949.
37. Sakaguchi, S.; Ono, M.; Setoguchi, R.; Yagi, H.; Hori, S.; Fehervari, Z.; Shimizu, J.; Takahashi, T.; Nomura, T. FoxP3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 2006, 212, 8-27.
38. Kerkvliet, N.I.; Shepherd, D.M.; Baecher-Steppan, L. T lymphocytes are direct, Aryl hydrocarbon Receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD. Toxicol. Appl. Pharmacol. 2002, 185, 146-152.
39. Frericks, M.; Meissner, M.; Esser, C. Microarray analysis of the AhR system: Tissue-specific flexibility in signal and target genes. Toxicol. Appl. Pharmacol. 2007, 220, 320-332.
40. Apetoh, L.; Quintana, F.; Pot, C.; Joller, N.; Xiao, S.; Kumar, D.; Burns, E.J.; Sherr, D.H.; Weiner, H.L.; Kuchroo, V.K. The Aryl hydrocarbon Receptor (AhR) interacts with c-Maf to promote the differentiation of IL-27-induced regulatory type 1 (TR1) cells. Nat. Immunol. 2010, 11, 854-861.
41. Lleo, A.; Bowlus, C.L.; Yang, G.X.; Invernizzi, P.; Podda, M.; van de Water, J.; Ansari, A.A.; Coppel, R.L.; Worman, H.J.; Gores, G.J.; et al. Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology 2010, 52, 987-998.
42. Selmi, C.; Meda, F.; Kasangian, A.; Invernizzi, P.; Tian, Z.; Lian, Z.; Podda, M.; Gershwin, M.E. Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell. Mol. Immunol. 2010, 7, 1-10.
43. Pollard, K.M.; Lee, D.K.; Casiano, C.A.; Bluthner, M.; Johnston, M.M.; Tan, E.M. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. J. Immunol. 1997, 158, 3521-3528.
44. Moscarello, M.A.; Mastronardi, F.G.; Wood, D.D. The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem. Res. 2007, 32, 251-256.
45. Doyle, H.A.; Mamula, M.J. Posttranslational protein modifications: New flavors in the menu of autoantigens. Curr. Opin. Rheumatol. 2002, 14, 244-249.
46. Doyle, H.A.; Mamula, M.J. Posttranslational modifications of self-antigens. Ann. N. Y. Acad. Sci. 2005, 1050, 1-9.
47. Papini, A.M. The use of post-translationally modified peptides for detection of biomarkers of immune-mediated diseases. J. Pept. Sci. 2009, 15, 621-628.
48. Thabet, Y.; Canas, F.; Ghedira, I.; Youinou, P.; Mageed, R.A.; Renaudineau, Y. Altered patterns of epigenetic changes in systemic lupus erythematosus and auto-antibody production: Is there a link? J. Autoimmun. 2012, 39, 154-160.
49. Hultman, P.; Turley, S.J.; Enestrom, S.; Lindh, U.; Pollard, K.M. Murine genotype influences the specificity, magnitude and persistence of murine mercury-induced autoimmunity. J. Autoimmun. 1996, 9, 139-149.
50. Pollard, K.M.; Pearson, D.L.; Hultman, P.; Hildebrandt, B.; Kono, D.H. Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity. Environ. Health Perspect. 1999, 107, 729-735.
51. Holmdahl, R.; Lorentzen, J.C.; Lu, S.; Olofsson, P.; Wester, L.; Holmberg, J.; Pettersson, U. Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol. Rev. 2001, 184, 184-202.
52. Reeves, W.H.; Lee, P.Y.; Weinstein, J.S.; Satoh, M.; Lu, L. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol. 2009, 30, 455-464.
53. Von Herrath, M.; Nepom, G.T. Animal models of human type 1 diabetes. Nat. Immunol. 2009, 10, 129-132.
54. Kamb, M.L.; Murphy, J.J.; Jones, J.L.; Caston, J.C.; Nederlof, K.; Horney, L.F.; Swygert, L.A.; Falk, H.; Kilbourne, E.M. Eosinophilia-myalgia syndrome in L-tryptophan-exposed patients. J. Am. Med. Assoc. 1992, 267, 77-82.
55. Parks, C.G.; Cooper, G.S.; Nylander-French, L.A.; Sanderson, W.T.; Dement, J.M.; Cohen, P.L.; Dooley, M.A.; Treadwell, E.L.; St Clair, E.W.; Gilkeson, G.S.; et al. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: A population-based, case-control study in the southeastern united states. Arthritis Rheumatol. 2002, 46, 1840-1850.
56. Stolt, P.; Yahya, A.; Bengtsson, C.; Kallberg, H.; Ronnelid, J.; Lundberg, I.; Klareskog, L.; Alfredsson, L.; EIRA Study Group. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Ann. Rheum. Dis. 2010, 69, 1072-1076.
57. Kettaneh, A.; Al Moufti, O.; Tiev, K.P.; Chayet, C.; Toledano, C.; Fabre, B.; Fardet, L.; Cabane, J. Occupational exposure to solvents and gender-related risk of systemic sclerosis: A metaanalysis of case-control studies. J. Rheumatol. 2007, 34, 97-103.
58. Sugiyama, D.; Nishimura, K.; Tamaki, K.; Tsuji, G.; Nakazawa, T.; Morinobu, A.; Kumagai, S. Impact of smoking as a risk factor for developing rheumatoid arthritis: A meta-analysis of observational studies. Ann. Rheum. Dis. 2010, 69, 70-81.
59. Bang, S.Y.; Lee, K.H.; Cho, S.K.; Lee, H.S.; Lee, K.W.; Bae, S.C. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Arthritis Rheumatol. 2010, 62, 369-377.
60. Harel-Meir, M.; Sherer, Y.; Shoenfeld, Y. Tobacco smoking and autoimmune rheumatic diseases. Nat. Clin. Pract. Rheumatol. 2007, 3, 707-715.
61. Mahid, S.S.; Minor, K.S.; Soto, R.E.; Hornung, C.A.; Galandiuk, S. Smoking and inflammatory bowel disease: A meta-analysis. Mayo Clin. Proc. 2006, 81, 1462-1471.
62. Beretich, B.D.; Beretich, T.M. Explaining multiple sclerosis prevalence by ultraviolet exposure: A geospatial analysis. Mult. Scler. 2009, 15, 891-898.
63. Kagnoff, M.F. Coeliac disease: Genetic, immunological and environmental factors in disease pathogenesis. Scand. J. Gastroenterol. Suppl. 1985, 114, 45-54.
64. Posada de la Paz, M.; Philen, R.M.; Borda, A.I. Toxic oil syndrome: The perspective after 20 years. Epidemiol. Rev. 2001, 23, 231-247.
65. Hamilton, C.M.; Strader, L.C.; Pratt, J.G.; Maiese, D.; Hendershot, T.; Kwok, R.K.; Hammond, J.A.; Huggins, W.; Jackman, D.; Pan, H.; et al. The phenx toolkit: Get the most from your measures. Am. J. Epidemiol. 2011, 174, 253-260.
66. Parks, C.G.; Cooper, G.S.; Nylander-French, L.A.; Hoppin, J.A.; Sanderson, W.T.; Dement, J.M. Comparing questionnaire-based methods to assess occupational silica exposure. Epidemiology 2004, 15, 433-441.
67. Parks, C.G.; Cooper, G.S.; Nylander-French, L.A.; Storm, J.F.; Archer, J.D. Assessing exposure to crystalline silica from farm work: A population-based study in the southeastern united states. Ann. Epidemiol. 2003, 13, 385-392.
68. Hart, J.E.; Kallberg, H.; Laden, F.; Bellander, T.; Costenbader, K.H.; Holmqvist, M.; Klareskog, L.; Alfredsson, L.; Karlson, E.W. Ambient air pollution exposures and risk of rheumatoid arthritis: Results from the swedish eira case-control study. Ann. Rheum. Dis. 2012, 72, 888-894.
69. Love, L.A.; Weinberg, C.R.; McConnaughey, D.R.; Oddis, C.V.; Medsger, T.A., Jr.; Reveille, J.D.; Arnett, F.C.; Targoff, I.N.; Miller, F.W. Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheumatol. 2009, 60, 2499-2504.
70. Verner, M.A.; Charbonneau, M.; Lopez-Carrillo, L.; Haddad, S. Physiologically based pharmacokinetic modeling of persistent organic pollutants for lifetime exposure assessment: A new tool in breast cancer epidemiologic studies. Environ. Health Perspect. 2008, 116, 886-892.
71. Peters, S.; Vermeulen, R.; Portengen, L.; Olsson, A.; Kendzia, B.; Vincent, R.; Savary, B.; Lavoué, J.; Cavallo, D.; Cattaneo, A.; et al. Modelling of occupational respirable crystalline silica exposure for quantitative exposure assessment in community-based case-control studies. J. Environ. Monit. 2011, 13, 3262-3268.
72. Armstrong, T.W.; Liang, Y.; Hetherington, Y.; Bowes, S.M., 3rd; Wong, O.; Fu, H.; Chen, M.; Schnatter, A.R. Retrospective occupational exposure assessment for case-control and case-series epidemiology studies based in Shanghai China. J. Occup. Environ. Hyg. 2011, 8, 561-572.
73. Patel, C.J.; Bhattacharya, J.; Butte, A.J. An environment-wide association study (EWAS) on type 2 diabetes mellitus. PLoS One 2010, 5, e10746.
74. Patel, C.J.; Chen, R.; Butte, A.J. Data-driven integration of epidemiological and toxicological data to select candidate interacting genes and environmental factors in association with disease. Bioinformatics 2012, 28, i121-i126.
75. Miller, F.W.; Pollard, K.M.; Parks, C.G.; Germolec, D.R.; Leung, P.S.; Selmi, C.; Humble, M.C.; Rose, N.R. Criteria for environmentally associated autoimmune diseases. J. Autoimmun. 2012, 39, 253-258.
76. Pollard, K.M.; Pearson, D.L.; Hultman, P.; Deane, T.N.; Lindh, U.; Kono, D.H. Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone BXSB mice. Environ. Health Perspect. 2001, 109, 27-33.
77. Kono, D.H.; Park, M.S.; Szydlik, A.; Haraldsson, K.M.; Kuan, J.D.; Pearson, D.L.; Hultman, P.; Pollard, K.M. Resistance to xenobiotic-induced autoimmunity maps to chromosome 1. J. Immunol. 2001, 167, 2396-2403.
78. Li, J.; McMurray, R.W. Effects of chronic exposure to DDT and TCDD on disease activity in murine systemic lupus erythematosus. Lupus 2009, 18, 941-949.
79. Mustafa, A.; Holladay, S.D.; Witonsky, S.; Sponenberg, D.P.; Karpuzoglu, E.; Gogal, R.M., Jr. A single mid-gestation exposure to tcdd yields a postnatal autoimmune signature, differing by sex, in early geriatric C57BL/6 mice. Toxicology 2011, 290, 156-168.
80. Klareskog, L.; Stolt, P.; Lundberg, K.; Kallberg, H.; Bengtsson, C.; Grunewald, J.; Rönnelid, J.; Harris, H.E.; Ulfgren, A.K.; Rantapää-Dahlqvist, S.; et al. A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheumatol. 2006, 54, 38-46.
81. Mikuls, T.R.; Levan, T.; Gould, K.A.; Yu, F.; Thiele, G.M.; Bynote, K.K.; Conn, D.; Jonas, B.L.; Callahan, L.F.; Smith, E.; et al. Impact of interactions of cigarette smoking with NAT2 polymorphisms on rheumatoid arthritis risk in african americans. Arthritis Rheumatol. 2012, 64, 655-664.
82. Karlson, E.W.; Chang, S.C.; Cui, J.; Chibnik, L.B.; Fraser, P.A.; de Vivo, I.; Costenbader, K.H. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann. Rheum. Dis. 2010, 69, 54-60.
83. Kallberg, H.; Ding, B.; Padyukov, L.; Bengtsson, C.; Ronnelid, J.; Klareskog, L.; Alfredsson, L.; EIRA Study Group. Smoking is a major preventable risk factor for rheumatoid arthritis: Estimations of risks after various exposures to cigarette smoke. Ann. Rheum. Dis. 2011, 70, 508-511.
84. Ospelt, C.; Camici, G.G.; Engler, A.; Kolling, C.; Vogetseder, A.; Gay, R.E.; Michel, B.A.; Gay, S. Smoking induces transcription of the heat shock protein system in the joints. Ann. Rheum. Dis. 2014, 73, 1423-1426.
85. Newkirk, M.M.; Mitchell, S.; Procino, M.; Li, Z.; Cosio, M.; Mazur, W.; Kinnula, V.L.; Hudson, M.; Baron, M.; Fritzler, M.J.; et al. Chronic smoke exposure induces rheumatoid factor and anti-heat shock protein 70 autoantibodies in susceptible mice and humans with lung disease. Eur. J. Immunol. 2012, 42, 1051-1061.
86. Yang, Y.; Yang, J.; Xie, R.; Ren, Y.; Fan, H. Regulatory effect of nicotine on collagen-induced arthritis and on the induction and function of in vitro-cultured Th17 cells. Mod. Rheumatol. 2014, in press.
87. Lindblad, S.S.; Mydel, P.; Jonsson, I.M.; Senior, R.M.; Tarkowski, A.; Bokarewa, M. Smoking and nicotine exposure delay development of collagen-induced arthritis in mice. Arthritis Res. Ther. 2009, 11, R88.
88. Pfau, J.C.; Serve, K.M.; Noonan, C.W. Autoimmunity and asbestos exposure. Autoimmune Dis. 2014, 2014, 782045.
89. Hayashi, H.; Miura, Y.; Maeda, M.; Murakami, S.; Kumagai, N.; Nishimura, Y.; Kusaka, M.; Urakami, K.; Fujimoto, W.; Otsuki, T. Reductive alteration of the regulatory function of the CD4(+) CD25(+) T cell fraction in silicosis patients. Int. J. Immunopathol. Pharmacol. 2010, 23, 1099-1109.
90. Otsuki, T.; Hayashi, H.; Nishimura, Y.; Hyodo, F.; Maeda, M.; Kumagai, N.; Miura, Y.; Kusaka, M.; Uragami, K. Dysregulation of autoimmunity caused by silica exposure and alteration of Fas-mediated apoptosis in T lymphocytes derived from silicosis patients. Int. J. Immunopathol. Pharmacol. 2011, 24, 11S-16S.
91. Conrad, K.; Mehlhorn, J.; Luthke, K.; Dorner, T.; Frank, K.H. Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: Clinical and serological characteristics. Lupus 1996, 5, 62-69.
92. Nietert, P.J.; Sutherland, S.E.; Silver, R.M.; Pandey, J.P.; Knapp, R.G.; Hoel, D.G.; Dosemeci, M. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheumatol. 1998, 41, 1111-1118.
93. Cooper, G.S.; Makris, S.L.; Nietert, P.J.; Jinot, J. Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans. Environ. Health Perspect. 2009, 117, 696-702.
94. Veldhoen, M.; Hirota, K.; Westendorf, A.M.; Buer, J.; Dumoutier, L.; Renauld, J.C.; Stockinger, B. The Aryl hydrocarbon Receptor links Th17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453, 106-109.
95. Quintana, F.J.; Basso, A.S.; Iglesias, A.H.; Korn, T.; Farez, M.F.; Bettelli, E.; Caccamo, M.; Oukka, M.; Weiner, H.L. Control of Treg and Th17 cell differentiation by the Aryl hydrocarbon Receptor. Nature 2008, 453, 65-71.
96. Farhat, S.C.; Silva, C.A.; Orione, M.A.; Campos, L.M.; Sallum, A.M.; Braga, A.L. Air pollution in autoimmune rheumatic diseases: A review. Autoimmun. Rev. 2011, 11, 14-21.
97. Lee, S.; Hayashi, H.; Maeda, M.; Chen, Y.; Matsuzaki, H.; Takei-Kumagai, N.; Nishimura, Y.; Fujimoto, W.; Otsuki, T. Environmental factors producing autoimmune dysregulation-Chronic activation of T cells caused by silica exposure. Immunobiology 2012, 217, 743-748.
98. Baccarelli, A.; Wright, R.O.; Bollati, V.; Tarantini, L.; Litonjua, A.A.; Suh, H.H.; Zanobetti, A.; Sparrow, D.; Vokonas, P.S.; Schwartz, J. Rapid DNA methylation changes after exposure to traffic particles. Am. J. Respir. Crit. Care Med. 2009, 179, 572-578.
99. Kerfoot, S.M.; Long, E.M.; Hickey, M.J.; Andonegui, G.; Lapointe, B.M.; Zanardo, R.C.; Bonder, C.; James, W.G.; Robbins, S.M.; Kubes, P. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J. Immunol. 2004, 173, 7070-7077.
100. Kimura, A.; Naka, T.; Nohara, K.; Fujii-Kuriyama, Y.; Kishimoto, T. Aryl hydrocarbon Receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc. Natl. Acad. Sci. USA 2008, 105, 9721-9726.
101. Ho, P.P.; Steinman, L. The Aryl hydrocarbon Receptor: A regulator of Th17 and Treg cell development in disease. Cell Res. 2008, 18, 605-608.